Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuancheng Zhao

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pediatric Health, Medicine and Therapeutics|March 24, 2026
Orbital Langerhans Cell Histiocytosis in Young Pediatric Patients: Two Case Reports and Literature ReviewPan Long, Yunjia Liu, Yuancheng Zhao, et al.
Frontiers in Medicine|February 20, 2026
A clinical observation of carbon dioxide laser-assisted deep sclerectomy for Posner-Schlossman SyndromeTao Luo, Jun Jiang, Sanni Yang, et al.
Renal Failure|July 2, 2024
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney diseaseQing Yang, Yutong Zou, Yanlin Lang, et al.
Haematologica|September 26, 2024
Safety and efficacy of human amniotic epithelial stem cell eye drops in ocular chronic graft-<i>versus</i>-host diseaseXianjing Cheng, Wei Fan, Ruihao Huang, et al.
Frontiers in Pharmacology|December 26, 2022
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched studyXiang Xiao, Junlin Zhang, Shuming Ji, et al.
Frontiers in Endocrinology|October 24, 2022
Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney diseaseXiang Xiao, Junlin Zhang, Shuming Ji, et al.
Renal Failure|February 23, 2023
The association of plasma NT-proBNP level and progression of diabetic kidney diseaseYuancheng Zhao, Lijun Zhao, Yiting Wang, et al.
Endocrine|August 10, 2024
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort studyYuancheng Zhao, Ke Liu, Yutong Zou, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 6, 2025
Efficacy and safety of ultrasound combined with microbubbles for treating retinal artery occlusion in ratsSen Fan, Yonghong Tang, Xinying Hu, et al.
Acta Diabetologica|November 2, 2022
Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort studyYutong Zou, Lijun Zhao, Junlin Zhang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pediatric Health, Medicine and Therapeutics|March 24, 2026
Orbital Langerhans Cell Histiocytosis in Young Pediatric Patients: Two Case Reports and Literature ReviewPan Long, Yunjia Liu, Yuancheng Zhao, et al.
Frontiers in Medicine|February 20, 2026
A clinical observation of carbon dioxide laser-assisted deep sclerectomy for Posner-Schlossman SyndromeTao Luo, Jun Jiang, Sanni Yang, et al.
Renal Failure|July 2, 2024
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney diseaseQing Yang, Yutong Zou, Yanlin Lang, et al.
Haematologica|September 26, 2024
Safety and efficacy of human amniotic epithelial stem cell eye drops in ocular chronic graft-<i>versus</i>-host diseaseXianjing Cheng, Wei Fan, Ruihao Huang, et al.
Frontiers in Pharmacology|December 26, 2022
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched studyXiang Xiao, Junlin Zhang, Shuming Ji, et al.
Frontiers in Endocrinology|October 24, 2022
Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney diseaseXiang Xiao, Junlin Zhang, Shuming Ji, et al.
Renal Failure|February 23, 2023
The association of plasma NT-proBNP level and progression of diabetic kidney diseaseYuancheng Zhao, Lijun Zhao, Yiting Wang, et al.
Endocrine|August 10, 2024
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort studyYuancheng Zhao, Ke Liu, Yutong Zou, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 6, 2025
Efficacy and safety of ultrasound combined with microbubbles for treating retinal artery occlusion in ratsSen Fan, Yonghong Tang, Xinying Hu, et al.
Acta Diabetologica|November 2, 2022
Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort studyYutong Zou, Lijun Zhao, Junlin Zhang, et al.
Pageof 3